MG occurs when the immune system produces antibodies that block or destroy communication between nerves and muscles. The exact cause is not fully understood, but it is considered an autoimmune disorder in most cases.

No, MG is not contagious. It is an autoimmune condition and cannot be spread from person to person.

Myasthenia Gravis (MG) symptoms often include muscle weakness that worsens with activity and improves with rest. Common signs include drooping eyelids, double vision, difficulty swallowing or speaking, persistent fatigue, and weakness in the arms, legs, neck, or breathing muscles. Some people also experience impaired balance, mobility issues, and trouble with chewing or holding up their head - especially later in the day.

MG is diagnosed through a combination of clinical evaluation, antibody blood tests, nerve conduction studies, and imaging of the thymus gland.

There is currently no cure for MG, but treatments are available to help manage symptoms and improve quality of life.

Recent progress in understanding the immune system’s role in Myasthenia Gravis (MG) has led to important improvements in diagnosis and treatment approaches. These advancements aim to help individuals with MG better manage their condition and improve overall quality of life.

However, despite available treatments, many people with MG continue to face ongoing physical, emotional, and social challenges. Access to care is not always equal, and treatment responses vary widely.

That’s why continued research, clinical trials, and advocacy are critical – to uncover more effective therapies, improve accessibility, and provide renewed hope for people living with MG. This is a time of momentum and optimism in the field, with promising developments on the horizon.

MG is a chronic neurological condition. While treatments can reduce MG symptoms many people with MG still experience ongoing MG symptoms that limit their daily functioning and quality of life, There is a need for improved access to treatments and research to develop new treatments that could improve the quality of life of people with MG.